Dr Reddy's Laboratories launches Ramelteon Tablets in US Market
23rd Jul 2019

Dr. Reddy's Laboratories has launched Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration (USFDA).

The company’s Ramelteon Tablets, are available as 8 mg tablets in bottle count sizes of 30, 100, and 1000. According to IQVIA Health, the Rozerem brand had U.S. sales of approximately $91.3 million MAT for the most recent twelve months ending in May 2019.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.